Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

7 recruiting

Enrollment Performance

Analytics

Phase 4

2(50.0%)

N/A

1(25.0%)

Phase 3

1(25.0%)

4Total

Phase 4(2)

N/A(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06282718Recruiting

A Long-term Observational Study Evaluating the Presentation and Management of Acute Respiratory Tract Infections in Primary Care Across Europe

Role: lead

NCT05993442Not ApplicableRecruiting

Optimising Kangaroo Care to Reduce Neonatal Severe Infection/Sepsis and Resistant Bacterial Colonisation Among High-risk Infants in NICU.

Role: collaborator

NCT07280572Phase 3Enrolling By Invitation

RECLAIM Adaptive Platform Trial for PCC Treatments

Role: collaborator

NCT07004049Phase 4Recruiting

Optimising TREATment for Severe Gram-Negative Bacterial Infections

Role: collaborator

NCT06156566Phase 4Recruiting

European Trial Into Mpox Infection

Role: collaborator

NCT05814237Recruiting

POS-ARI-ER Observational Study of Acute Respiratory Infections

Role: lead

NCT05719259Recruiting

Perpetual Observational Study - Ventilator Associated Pneumonia

Role: lead

NCT05458700Recruiting

POS-cUTI: Study on Complicated Urinary Tract Infections

Role: lead

All 8 trials loaded